Feature Channels:

Vaccines

Add to Favorites Subscribe Share
fbshare-Vaccines

Showing results

110 of 1016
Embargo will expire:
29-Apr-2019 11:00 AM EDT
Released to reporters:
25-Apr-2019 2:05 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 29-Apr-2019 11:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

GEORGIA-FS-FC_1.jpg

Article ID: 711937

UGA College of Pharmacy and CDC develop single-dose vaccine to protect against Crimean-Congo Hemorraghic Fever Virus

University of Georgia

Research teams at the University of Georgia College of Pharmacy Department of Pharmaceutical and Biomedical Sciences, led by Associate Professor Scott Pegan, in collaboration with the Centers for Disease Control, led by Éric Bergeron, have successfully discovered a single-dose replicon particle vaccine that provides complete protection against the Crimean-Congo Hemorraghic Fever (CCHF) virus in mice.

Released:
25-Apr-2019 1:05 PM EDT
HCGHDr.ChoowithBaby002.jpg

Article ID: 711810

Tip Sheet: Studies on Obesity, Opioids And Vaccines Among Hopkins Research to Be Presented at National Pediatrics Meeting

Johns Hopkins Medicine

What: Pediatric Academic Societies (PAS) 2019 Meeting When: April 27-30, 2019 Where: Baltimore Convention Center (1 W. Pratt St, Baltimore, Maryland 21201)

Released:
24-Apr-2019 10:00 AM EDT
PIC_10-17_POR_Turner.jpg

Article ID: 711686

Texas Biomed VP Named Executive Director of the Vaccine Development Center of San Antonio

Texas Biomedical Research Institute

Professor Joanne Turner, Ph.D., the Vice President for Research at Texas Biomedical Research Institute, will serve as the new Executive Director of the Vaccine Development Center of San Antonio.

Released:
22-Apr-2019 11:05 AM EDT
hms-logo.gif

Article ID: 711583

A Mother Lode of Protection

Harvard Medical School

Now research conducted in mice offers new hope that neonatal herpes infections might eventually be avoidable by stimulating an immune response in mothers.

Released:
18-Apr-2019 1:05 PM EDT
JonJulianoIrvingHoffmanRTSSShepardAward2015.jpg

Article ID: 711532

U.S. and Malawian Partners Implement Malaria Vaccine for Children in Africa

University of North Carolina School of Medicine

The first malaria vaccine will be tested in a pilot study beginning this April in three countries with a high burden of the disease among children, according to researchers leading the trial from UNC Project-Malawi. There, malaria is the main cause of illness and death among children under age 5.

Released:
17-Apr-2019 4:05 PM EDT
idsanoclipspelledout2.png

Article ID: 711522

Fact Not Fiction: Measles Vaccine Is Safe, Effective and Lifesaving

Infectious Diseases Society of America (IDSA)

The Infectious Diseases Society of America Dispels Dangerous Measles Vaccine Myths

Released:
17-Apr-2019 2:45 PM EDT
JHSPH-new-logo.jpg

Article ID: 711409

PCV10 Pneumococcal Vaccine Has Big Impact in Kenya, Even Among Unvaccinated Individuals

Johns Hopkins Bloomberg School of Public Health

A vaccine against Streptococcus pneumoniae, a major cause of childhood illness and mortality in the developing world, sharply reduced the incidence of serious pneumococcal disease among children in a large Kenyan community after it was introduced in 2011, according to a new study from researchers at the Johns Hopkins Bloomberg School of Public Health.

Released:
16-Apr-2019 10:45 AM EDT
UNCTMIMSNatureMicrobiologyLiverRNAPub.jpg

Article ID: 711319

U.S. and Japanese Researchers Identify How Liver Cells Protect Against Viral Attacks

University of North Carolina School of Medicine

Researchers in Chapel Hill, N.C., and Tokyo have discovered a mechanism by which liver cells intrinsic resistance to diverse RNA viruses is regulated. These results have implications for for cellular responses to hepatitis, dengue and Zika.

Released:
15-Apr-2019 11:00 AM EDT
Jefferson4CHP3002.jpg
  • Embargo expired:
    15-Apr-2019 5:00 AM EDT

Article ID: 711134

Developing a Vaccine Against Nipah Virus

Thomas Jefferson University

Researchers developed a novel recombinant vaccine called NIPRAB that shows robust immunization against Nipah virus in animal models and may be effective against other viruses in the same family.

Released:
11-Apr-2019 8:05 AM EDT

Showing results

110 of 1016

Chat now!